| For: | Nakanuma Y, Sato Y, Harada K, Sasaki M, Xu J, Ikeda H. Pathological classification of intrahepatic cholangiocarcinoma based on a new concept. World J Hepatol 2010; 2(12): 419-427 [PMID: 21191517 DOI: 10.4254/wjh.v2.i12.419] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v2/i12/419.htm |
| Number | Citing Articles |
| 1 |
Linda D. Ferrell, Sanjay Kakar, Luigi M. Terracciano, Aileen Wee. MacSween's Pathology of the Liver. 2024; doi: 10.1016/B978-0-7020-8228-3.00013-2
|
| 2 |
Hoon Jai Chun, Seun Ja Park, Yun Jeong Lim, Si Young Song. Gastrointestinal Cancer. 2023; doi: 10.1007/978-981-99-0815-8_53
|
| 3 |
Benjamin Goeppert, Reka Toth, Stephan Singer, Thomas Albrecht, Daniel B. Lipka, Pavlo Lutsik, David Brocks, Marion Baehr, Oliver Muecke, Yassen Assenov, Lei Gu, Volker Endris, Albrecht Stenzinger, Arianeb Mehrabi, Peter Schirmacher, Christoph Plass, Dieter Weichenhan, Stephanie Roessler. Integrative Analysis Defines Distinct Prognostic Subgroups of Intrahepatic Cholangiocarcinoma. Hepatology 2019; 69(5) doi: 10.1002/hep.30493
|
| 4 |
Jordan L. Plieskatt, Gabriel Rinaldi, Yanjun Feng, Jin Peng, Ponlapat Yonglitthipagon, Samantha Easley, Therawach Laha, Chawalit Pairojkul, Vajarabhongsa Bhudhisawasdi, Banchob Sripa, Paul J. Brindley, Jason P. Mulvenna, Jeffrey M. Bethony. Distinct miRNA signatures associate with subtypes of cholangiocarcinoma from infection with the tumourigenic liver fluke Opisthorchis viverrini. Journal of Hepatology 2014; 61(4) doi: 10.1016/j.jhep.2014.05.035
|
| 5 |
Mi-Suk Park. Review of Mass-Forming Intrahepatic Cholangiocarcinoma. Korean Journal of Abdominal Radiology 2022; 6(1) doi: 10.52668/kjar.2022.00150
|
| 6 |
Riccardo Faletti, Davide Ippolito, Sandro Sironi, Luigi Grazioli, Michele Nardella, Eleonora Tricarico, Marco Gatti, Cesare Maino, Riccardo Inchingolo. Gadoxetic acid magnetic-enhanced resonance imaging in the diagnosis of cholangiocarcinoma. World Journal of Gastroenterology 2020; 26(29): 4261-4271 doi: 10.3748/wjg.v26.i29.4261
|
| 7 |
Aya Shinozaki, Junji Shibahara, Naohiro Noda, Mariko Tanaka, Taku Aoki, Norihiro Kokudo, Masashi Fukayama. Claudin-18 in biliary neoplasms. Its significance in the classification of intrahepatic cholangiocarcinoma. Virchows Archiv 2011; 459(1) doi: 10.1007/s00428-011-1092-z
|
| 8 |
Rares Ilie Orzan, Cristina Pojoga, Renata Agoston, Radu Seicean, Andrada Seicean. Endoscopic Ultrasound in the Diagnosis of Extrahepatic Cholangiocarcinoma: What Do We Know in 2023?. Diagnostics 2023; 13(6) doi: 10.3390/diagnostics13061023
|
| 9 |
Narong Khuntikeo, Ake Pugkhem, Tharatip Srisuk, Vor Luvira, Attapol Titapun, Theerawee Tipwaratorn, Vasin Thanasukarn, Vivian Klungboonkrong, Jitraporn Wongwiwatchai. Liver Fluke, Opisthorchis viverrini Related Cholangiocarcinoma. Recent Results in Cancer Research 2023; 219 doi: 10.1007/978-3-031-35166-2_7
|
| 10 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; doi: 10.1007/978-3-319-26956-6_35
|
| 11 |
Ijin Joo. Recent Updates in the Imaging Diagnosis of Cholangiocarcinoma. Journal of the Korean Society of Radiology 2019; 80(3) doi: 10.3348/jksr.2019.80.3.394
|
| 12 |
Tao Wang, Esther Drill, Efsevia Vakiani, Linda Ma Pak, Thomas Boerner, Gokce Askan, Juan Manuel Schvartzman, Amber L. Simpson, William R. Jarnagin, Carlie S. Sigel. Distinct histomorphological features are associated with IDH1 mutation in intrahepatic cholangiocarcinoma. Human Pathology 2019; 91 doi: 10.1016/j.humpath.2019.05.002
|
| 13 |
Shao-hua Chen, Zhi-yong Zheng, Hanlin L. Wang, Ying-hao Yu, De-hua Zeng, Li-juan Qu, Xian-zong Ye. Thyroid-Like Intrahepatic Cholangiocarcinoma: Report of a Case and Review of the Literature. International Journal of Surgical Pathology 2018; 26(7) doi: 10.1177/1066896918769381
|
| 14 |
S. Di Matteo, L. Nevi, D. Costantini, D. Overi, G. Carpino, S. Safarikia, F. Giulitti, C. Napoletano, E. Manzi, A. M. De Rose, F. Melandro, M. Bragazzi, P. B. Berloco, F. Giuliante, G. Grazi, A. Giorgi, V. Cardinale, L. Adorini, E. Gaudio, D. Alvaro, Gianfranco D. Alpini. The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma. PLOS ONE 2019; 14(1) doi: 10.1371/journal.pone.0210077
|
| 15 |
Philip Berry, Sreelakshmi Kotha, Lynn Affarah. Beyond futility: The history and potential of liver transplantation in cholangiocarcinoma. World Journal of Transplantation 2025; 15(4): 105649 doi: 10.5500/wjt.v15.i4.105649
|
| 16 |
Muhammad Salman Azhar, Zi-jian Zhang, Zhong-tao Liu, Yun-peng Huang, Yong-xiang Wang, Hui Zhou, Li Xiong, Yu Wen, Heng Zou. Prognostic models for mucinous and non-specific adeno cholangiocarcinoma: a population-based retrospective study. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1284283
|
| 17 |
Javier Sempere, Celia Baez de Burgos, Mireia Gil-Raga, Isabel Iranzo, Patricia Suárez, Ana B Durá, Luis Ferrer-Barceló, Cecilia Albert, Carlos Boix, José Mir Labrador, Miriam Lobo, José María Huguet. Diagnostic-therapeutic management of bile duct cancer. World Journal of Clinical Cases 2019; 7(14): 1732-1752 doi: 10.12998/wjcc.v7.i14.1732
|
| 18 |
Sarinya Kongpetch, Apinya Jusakul, Choon Kiat Ong, Weng Khong Lim, Steven G. Rozen, Patrick Tan, Bin Tean Teh. Pathogenesis of cholangiocarcinoma: From genetics to signalling pathways. Best Practice & Research Clinical Gastroenterology 2015; 29(2) doi: 10.1016/j.bpg.2015.02.002
|
| 19 |
Masahide Ikeguchi, Kanenori Endo. Clinicopathological difference between invasive pancreatic duct cancer and distal bile duct cancer of the pancreas head after pancreaticoduodenectomy. International Journal of Hepatobiliary and Pancreatic Diseases 2020; 10(1) doi: 10.5348/100090Z04MI2020RA
|
| 20 |
Wen-Ming Cong, Hui Dong, Yu-Yao Zhu, Zhen Zhu. Surgical Pathology of Hepatobiliary Tumors. 2017; doi: 10.1007/978-981-10-3536-4_7
|
| 21 |
Richard Tang, Nicholas Latchana, Amir A. Rahnemai-Azar, Timothy M. Pawlik. Primary and Metastatic Liver Tumors. 2018; doi: 10.1007/978-3-319-91977-5_8
|
| 22 |
Matteo Fassan, Valentina Angerilli, Nicola Normanno, Giancarlo Pruneri, Antonio Marchetti, Federica Grillo, Giuseppe Tonini, Aldo Scarpa, Lorenza Rimassa. Practical guidelines for molecular testing of cholangiocarcinoma in clinical practice: Italian experts’ position paper. Critical Reviews in Oncology/Hematology 2024; 194 doi: 10.1016/j.critrevonc.2023.104224
|
| 23 |
Hongguang Li, Lingxin Qu, Haibin Zhang, Jun Liu, Xiaolu Zhang. A comprehensive transcriptomic landscape of cholangiocarcinoma based on bioinformatics analysis from large cohort of patients. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-93250-4
|
| 24 |
Divya Khosla, Shagun Misra, Pek Lim Chu, Peiyong Guan, Ritambhra Nada, Rajesh Gupta, Khwanta Kaewnarin, Tun Kiat Ko, Hong Lee Heng, Vijay Kumar Srinivasalu, Rakesh Kapoor, Deepika Singh, Poramate Klanrit, Somponnat Sampattavanich, Jing Tan, Sarinya Kongpetch, Apinya Jusakul, Bin Tean Teh, Jason Yongsheng Chan, Jing Han Hong. Cholangiocarcinoma: Recent Advances in Molecular Pathobiology and Therapeutic Approaches. Cancers 2024; 16(4) doi: 10.3390/cancers16040801
|
| 25 |
Mukul Vij, Yogesh Puri, Ashwin Rammohan, Gowripriya G, Rajesh Rajalingam, Ilankumaran Kaliamoorthy, Mohamed Rela. Pathological, molecular, and clinical characteristics of cholangiocarcinoma: A comprehensive review. World Journal of Gastrointestinal Oncology 2022; 14(3): 607-627 doi: 10.4251/wjgo.v14.i3.607
|
| 26 |
Paola Mattiolo, Mario De Bellis, Andrea Mafficini, Matteo Fassan, Michele Bevere, Calogero Ciulla, Samantha Bersani, Rita T. Lawlor, Michele Milella, Aldo Scarpa, Claudio Luchini, Andrea Ruzzenente. Long-Term Survivor of Intrahepatic Cholangiocarcinoma for over 18 Years: Case Study with Longitudinal Histo-molecular and Tumor Immune Microenvironment Characterization and Systematic Review of the Literature. Journal of Gastrointestinal Cancer 2024; 55(4) doi: 10.1007/s12029-024-01113-8
|
| 27 |
Ines Malenica, Matteo Donadon, Ana Lleo. Molecular and Immunological Characterization of Biliary Tract Cancers: A Paradigm Shift Towards a Personalized Medicine. Cancers 2020; 12(8) doi: 10.3390/cancers12082190
|
| 28 |
Rakesh Sahu, Praveen Sharma, Ajay Kumar. An Insight into Cholangiocarcinoma and Recent Advances in its Treatment. Journal of Gastrointestinal Cancer 2023; 54(1) doi: 10.1007/s12029-021-00728-5
|
| 29 |
Jing Xu, Saya Igarashi, Motoko Sasaki, Takashi Matsubara, Norihide Yoneda, Kazuto Kozaka, Hiroko Ikeda, Jihun Kim, Eunsil Yu, Osamu Matsui, Yasuni Nakanuma. Intrahepatic cholangiocarcinomas in cirrhosis are hypervascular in comparison with those in normal livers. Liver International 2012; 32(7) doi: 10.1111/j.1478-3231.2012.02783.x
|
| 30 |
Vincenzo Cardinale, Guido Carpino, Lola M. Reid, Eugenio Gaudio, Domenico Alvaro. Cholangiocarcinoma: A cancer in search of the right classification. Hepatology 2012; 56(4) doi: 10.1002/hep.25705
|
| 31 |
Taek Chung, Hyungjin Rhee, Ji Hae Nahm, Youngsic Jeon, Jeong Eun Yoo, Young-Joo Kim, Dai Hoon Han, Young Nyun Park. Clinicopathological characteristics of intrahepatic cholangiocarcinoma according to gross morphologic type: cholangiolocellular differentiation traits and inflammation- and proliferation-phenotypes. HPB 2020; 22(6) doi: 10.1016/j.hpb.2019.10.009
|
| 32 |
Vincenzo Cardinale, Guido Carpino. Multilevel heterogeneity of biliary tract cancers may affect the modelling of prognosis. Liver International 2017; 37(12) doi: 10.1111/liv.13565
|
| 33 |
Francesca Saffioti, Davide Roccarina, Mette Vesterhus, Johannes R. Hov, William Rosenberg, Massimo Pinzani, Stephen P. Pereira, Kirsten M. Boberg, Douglas Thorburn. Cholangiocarcinoma is associated with a raised enhanced liver fibrosis score independent of primary sclerosing cholangitis. European Journal of Clinical Investigation 2019; 49(5) doi: 10.1111/eci.13088
|
| 34 |
|
| 35 |
Fardad Ejtehadi, Kamran Bagheri Lankarani, Gholam Reza Sivandzadeh, Ramin Niknam, Alireza Shamsaeefar, Firoozeh Tarkesh, Mohammad Foad Abazari, Amir Tajbakhsh, Ehsan Raeis-Abdollahi, Asaad Azarnezhad, Farshid Ejtehadi, Hassan Askari, Ali Reza Safarpour. Cholangiocarcinoma and liver transplantation: What we know so far?. World Journal of Gastrointestinal Pathophysiology 2021; 12(5): 84-105 doi: 10.4291/wjgp.v12.i5.84
|
| 36 |
Sungeun Park, Boyeon Koo, Boryeong Jeong, Sang Hyun Choi, Jeong Min Lee. LI-RADS Category Can Be a Post-Surgical Prognostic Factor for Intrahepatic Cholangiocarcinoma in Patients with Liver Cirrhosis or Chronic Hepatitis B. Liver Cancer 2024; doi: 10.1159/000539794
|
| 37 |
|
| 38 |
Yasuni Nakanuma, Yasunori Sato. Hilar cholangiocarcinoma is pathologically similar to pancreatic duct adenocarcinoma: suggestions of similar background and development. Journal of Hepato-Biliary-Pancreatic Sciences 2014; 21(7) doi: 10.1002/jhbp.70
|
| 39 |
Sang-Hoon Lee, Si Young Song. Recent Advancement in Diagnosis of Biliary Tract Cancer through Pathological and Molecular Classifications. Cancers 2024; 16(9) doi: 10.3390/cancers16091761
|
| 40 |
Vincenzo Cardinale, Yunfang Wang, Guido Carpino, Gemma Mendel, Gianfranco Alpini, Eugenio Gaudio, Lola M. Reid, Domenico Alvaro. The biliary tree—a reservoir of multipotent stem cells. Nature Reviews Gastroenterology & Hepatology 2012; 9(4) doi: 10.1038/nrgastro.2012.23
|
| 41 |
Keiichi Kubota, Yasuni Nakanuma, Fukuo Kondo, Hiroyuki Hachiya, Masaru Miyazaki, Masato Nagino, Masakazu Yamamoto, Hiroyuki Isayama, Masami Tabata, Hisafumi Kinoshita, Terumi Kamisawa, Kazuo Inui. Clinicopathological features and prognosis of mucin‐producing bile duct tumor and mucinous cystic tumor of the liver: a multi‐institutional study by the Japan Biliary Association. Journal of Hepato-Biliary-Pancreatic Sciences 2014; 21(3) doi: 10.1002/jhbp.23
|
| 42 |
Arezou Abbasi, Amir A. Rahnemai-Azar, Sean M. Ronnekleiv-Kelly, Daniel E. Abbott, Sharon M. Weber. Intrahepatic Cholangiocarcinoma. 2019; doi: 10.1007/978-3-030-22258-1_2
|
| 43 |
Domenico Alvaro, Eugenio Gaudio, Lola Reid, Guido Carpino, Vincenzo Cardinale. Multiple cells of origin in cholangiocarcinoma underlie biological, epidemiological and clinical heterogeneity. World Journal of Gastrointestinal Oncology 2012; 4(5): 94-102 doi: 10.4251/wjgo.v4.i5.94
|
| 44 |
Ann-Kathrin Lederer, Nele Görrissen, Tinh Thi Nguyen, Clemens Kreutz, Hannah Rasel, Fabian Bartsch, Hauke Lang, Kristina Endres. Exploring the effects of gut microbiota on cholangiocarcinoma progression by patient-derived organoids. Journal of Translational Medicine 2025; 23(1) doi: 10.1186/s12967-024-06012-x
|
| 45 |
Iyo Tanimura, Norihide Yoneda, Azusa kitao, Kouki Nio, Shuichi Kaneko, Mitsuyoshi Okazaki, Hiroko Ikeda, Satoshi Kobayashi, Toshifumi Gabata. A case of intrahepatic cholangiocarcinoma arising from a simple hepatic cyst via dysplasia and carcinomatous transformation. Abdominal Radiology 2022; 47(6) doi: 10.1007/s00261-022-03493-6
|
| 46 |
Kamran Qureshi, Randhir Jesudoss, Abdullah M. S. Al-Osaimi. The Treatment of Cholangiocarcinoma: a Hepatologist’s Perspective. Current Gastroenterology Reports 2014; 16(10) doi: 10.1007/s11894-014-0412-2
|
| 47 |
Yumiko Kageyama, Ryuzo Yamaguchi, Shinya Watanabe, Keiji Aizu, Fumiya Sato, Atsuki Arimoto. Intraductal papillary neoplasm of the bile duct with rapidly progressive multicentric recurrence. International Journal of Surgery Case Reports 2018; 51(C) doi: 10.1016/j.ijscr.2018.08.024
|
| 48 |
Jae Hoon Lim, Kee-Taek Jang, Jung Hoon Kim. Neoplasms of the Biliary Tract. 2021; doi: 10.1007/978-981-15-6659-2_7
|
| 49 |
Najib Ben Khaled, Sven Jacob, Daniel Rössler, Florian Bösch, Enrico N. De Toni, Jens Werner, Jens Ricke, Julia Mayerle, Max Seidensticker, Christian Schulz, Matthias P. Fabritius. Current State of Multidisciplinary Treatment in Cholangiocarcinoma. Digestive Diseases 2022; 40(5) doi: 10.1159/000520346
|
| 50 |
Jun Gu Kang, Taek Chung, Dong Kyu Kim, Hyungjin Rhee. Imaging findings of intrahepatic cholangiocarcinoma for prognosis
prediction and treatment decision-making: a narrative review. The Ewha Medical Journal 2024; 47(4) doi: 10.12771/emj.2024.e66
|
| 51 |
Hector Perez-Montoyo. Therapeutic Potential of Autophagy Modulation in Cholangiocarcinoma. Cells 2020; 9(3) doi: 10.3390/cells9030614
|
| 52 |
Tanachapa Jantalika, Sirikul Manochantr, Pakpoom Kheolamai, Duangrat Tantikanlayaporn, Nattaya Thongsepee, Naree Warnnissorn, Weerachai Saijuntha, Somchai Pinlaor, Chairat Tantrawatpan. The Human Placental Amniotic Membrane Mesenchymal-Stromal-Cell-Derived Conditioned Medium Inhibits Growth and Promotes Apoptosis of Human Cholangiocarcinoma Cells In Vitro and In Vivo by Suppressing IL-6/JAK2/STAT3 Signaling. Cells 2023; 12(24) doi: 10.3390/cells12242788
|
| 53 |
Sumera I. Ilyas, Gregory J. Gores. Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma. Gastroenterology 2013; 145(6) doi: 10.1053/j.gastro.2013.10.013
|
| 54 |
Kelly J. Lafaro, David Cosgrove, Jean-Francois H. Geschwind, Ihab Kamel, Joseph M. Herman, Timothy M. Pawlik. Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management. Gastroenterology Research and Practice 2015; 2015 doi: 10.1155/2015/860861
|
| 55 |
V. Karafiát, P. Veselý, Michal Dvořák. Egg Yolk Phospholipids Enriched with 1-O-Octadecyl-2-Oleoyl-sn-Glycero-3-Phospho-(N-Palmitoyl) Ethanolamine Inhibit Development of Experimentally Induced Tumours. Folia Biologica 2014; 60(5) doi: 10.14712/fb2014060050220
|
| 56 |
Baltasar Pérez Saborido, Martín Bailón Cuadrado, Mario Rodríguez López, Enrique Asensio Díaz, Beatriz Madrigal Rubiales, Asterio Barrera Rebollo. Intraductal papillary neoplasia of the bile duct with malignancy: A differentiated entity of cholangiocarcinoma with a better prognosis, a review of three new cases. Revista Española de Enfermedades Digestivas 2017; 109 doi: 10.17235/reed.2017.4835/2016
|
| 57 |
Dehua Wang, Darren Marshall, Gruschen Veldtman, Anita Gupta, Andrew T. Trout, Juan Villafane, Kevin Bove. Intrahepatic cholangiocarcinoma after Fontan procedure in an adult with visceral heterotaxy. Pathology - Research and Practice 2018; 214(6) doi: 10.1016/j.prp.2018.03.016
|
| 58 |
Vincenzo Cardinale. Classifications and misclassification in cholangiocarcinoma. Liver International 2019; 39(2) doi: 10.1111/liv.13998
|
| 59 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; doi: 10.1007/978-3-319-26587-2_29-1
|
| 60 |
Mihnea P. Dragomir, Teodor G. Calina, Eilís Perez, Simon Schallenberg, Meng Chen, Thomas Albrecht, Ines Koch, Peggy Wolkenstein, Benjamin Goeppert, Stephanie Roessler, George A. Calin, Christine Sers, David Horst, Florian Roßner, David Capper. DNA methylation-based classifier differentiates intrahepatic pancreato-biliary tumours. eBioMedicine 2023; 93 doi: 10.1016/j.ebiom.2023.104657
|
| 61 |
Alphonse E. Sirica. The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma. Nature Reviews Gastroenterology & Hepatology 2012; 9(1) doi: 10.1038/nrgastro.2011.222
|
| 62 |
Nataliya Razumilava, Gregory J. Gores. Classification, Diagnosis, and Management of Cholangiocarcinoma. Clinical Gastroenterology and Hepatology 2013; 11(1) doi: 10.1016/j.cgh.2012.09.009
|
| 63 |
学河 朱. Typing, Risk Factors and Related Treatments of Cholangiocarcinoma. Advances in Clinical Medicine 2014; 4(04) doi: 10.12677/ACM.2014.44014
|
| 64 |
Yasuni Nakanuma, Yasunori Sato, Hiroko Ikeda, Kenichi Harada, Mikiko Kobayashi, Kenji Sano, Takeshi Uehara, Masakazu Yamamoto, Shunichi Ariizumi, Young Nyun Park, Joon Hyuk Choi, Ensil Yu. Intrahepatic Cholangiocarcinoma With Predominant “Ductal Plate Malformation” Pattern. American Journal of Surgical Pathology 2012; 36(11) doi: 10.1097/PAS.0b013e31826e0249
|
| 65 |
Shun-ichi Ariizumi, Masakazu Yamamoto. Intrahepatic cholangiocarcinoma and cholangiolocellular carcinoma in cirrhosis and chronic viral hepatitis. Surgery Today 2015; 45(6) doi: 10.1007/s00595-014-1031-0
|
| 66 |
Hee Ju Sohn, Hongbeom Kim, Jae Ri Kim, Jae Sung Kang, Youngmin Han, Mirang Lee, Hyeong Seok Kim, Wooil Kwon, Suk Kyun Hong, YoungRok Choi, Nam-Joon Yi, Kwang-Woong Lee, Kyung-Suk Suh, Jin-Young Jang. Predicting prognosis and evaluating the benefits of adjuvant chemotherapy depending on the tumor location in intrahepatic cholangiocarcinoma: focusing on the involvement of below 2nd bile duct confluence. Annals of Surgical Treatment and Research 2022; 102(5) doi: 10.4174/astr.2022.102.5.248
|
| 67 |
Shun-ichi Ariizumi, Yoshihito Kotera, Satoshi Katagiri, Masayuki Nakano, Yasuni Nakanuma, Akiko Saito, Masakazu Yamamoto. Long-term Survival of Patients with Cholangiolocellular Carcinoma After Curative Hepatectomy. Annals of Surgical Oncology 2014; 21(S3) doi: 10.1245/s10434-014-3582-0
|
| 68 |
Yusuke Yamamoto, Hisashi Kosaka, Masaki Ueno, Hiroji Shinkawa, Satoshi Yasuda, Koji Komeda, Haruki Mori, Tsukasa Aihara, Shinya Hayami, Masahiko Kinoshita, Nao Kawaguchi, Atsushi Shiozaki, Takeaki Ishizawa, Shoji Kubo, Masaki Kaibori. Proposal and external validation of a prognosis-oriented TNM staging system for intrahepatic cholangiocarcinoma: A multicenter study from the Kansai region of Japan. Surgery 2026; 191 doi: 10.1016/j.surg.2025.110051
|
| 69 |
Emilie A. K. Warren, Shishir K. Maithel. The SAGES Manual of Contemporary Indications and Management of Hepatic and Biliary Diseases. 2025; doi: 10.1007/978-3-032-04823-3_5
|
| 70 |
Hepatobiliary Cancers: Translational Advances and Molecular Medicine. Advances in Cancer Research 2022; 156 doi: 10.1016/bs.acr.2022.01.010
|
| 71 |
Fabio Bagante, Matthew Weiss, Sorin Alexandrescu, Hugo P. Marques, Luca Aldrighetti, Shishir K. Maithel, Carlo Pulitano, Todd W. Bauer, Feng Shen, George A. Poultsides, Olivier Soubrane, Guillaume Martel, Bas G. Koerkamp, Alfredo Guglielmi, Endo Itaru, Timothy M. Pawlik. Long-term outcomes of patients with intraductal growth sub-type of intrahepatic cholangiocarcinoma. HPB 2018; 20(12) doi: 10.1016/j.hpb.2018.05.017
|
| 72 |
Soo Young Oh, Shin Hwang, Yumi Kim, Eun-Kyoung Jwa. Pancreaticoduodenectomy for recurrence of intraductal papillary neoplasm of bile duct at seven years after curative resection. Annals of Liver Transplantation 2022; 2(1) doi: 10.52604/alt.22.0007
|
| 73 |
Hyungjin Rhee, Myeong-Jin Kim, Young Nyun Park, Chansik An. A proposal of imaging classification of intrahepatic mass-forming cholangiocarcinoma into ductal and parenchymal types: clinicopathologic significance. European Radiology 2019; 29(6) doi: 10.1007/s00330-018-5898-9
|
| 74 |
Han Wang, Miao-Xia He, Wen-Ming Cong, Hui Dong. Immunohistochemistry in intrahepatic cholangiocarcinoma: histological subtyping and drug selection. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1653534
|
| 75 |
Kyung-Hun Lee, Kyoung-Bun Lee, Tae-Yong Kim, Sae-Won Han, Do-Youn Oh, Seock-Ah Im, Tae-You Kim, Nam-Joon Yi, Kwang-Woong Lee, Kyung-Suk Suh, Ja-June Jang, Yung-Jue Bang. Clinical and pathological significance of ROS1 expression in intrahepatic cholangiocarcinoma. BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1737-4
|
| 76 |
Louise Lee, Arumugam Rajesh. Approach to Biliary Malignancies. Journal of Gastrointestinal and Abdominal Radiology 2023; 6(03) doi: 10.1055/s-0043-57253
|
| 77 |
Nataliya Razumilava, Gregory J Gores. Cholangiocarcinoma. The Lancet 2014; 383(9935) doi: 10.1016/S0140-6736(13)61903-0
|
| 78 |
Takumu Hasebe, Koji Sawada, Hidemi Hayashi, Shunsuke Nakajima, Hiroyuki Takahashi, Masahiro Hagiwara, Koji Imai, Sayaka Yuzawa, Mikihiro Fujiya, Hiroyuki Furukawa, Toshikatsu Okumura. Long-term growth of intrahepatic papillary neoplasms: A case report. World Journal of Gastroenterology 2019; 25(36): 5569-5577 doi: 10.3748/wjg.v25.i36.5569
|
| 79 |
Yasuni Nakanuma, Yuko Kakuda. Pathologic classification of cholangiocarcinoma: New concepts. Best Practice & Research Clinical Gastroenterology 2015; 29(2) doi: 10.1016/j.bpg.2015.02.006
|
| 80 |
Domenico Alvaro, Cesare Hassan, Vincenzo Cardinale, Guido Carpino, Luca Fabris, Enrico Gringeri, Vincenza Granata, Massimiliano Mutignani, Helen Morement, Felice Giuliante, Alfredo Guglielmi, Lorenzo Ridola, Marco Marzioni, Gianluca Grazi, Maria Guido, Emilio Di Giulio, Giuseppe Tonini, Francesco Pantano, Rosanna Venere, Maria Consiglia Bragazzi, Francesca Biancanello, Jessica Faccioli, Aurora Giannetti, Marcello Cintolo, Michela Di Giunta, Martina Gambato, Alberto Lasagni, Francesco Izzo, Antonio Avallone, Jesus Banales, Massimo Rossi, Carlo Catalano, Andrea Laghi, Giulia D'amati, Maria Grazia Mancino, Lorenzo Ridola. Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging. Digestive and Liver Disease 2020; 52(11) doi: 10.1016/j.dld.2020.06.045
|
| 81 |
Hiep Nguyen Canh, Kenta Takahashi, Minako Yamamura, Zihan Li, Yasunori Sato, Kaori Yoshimura, Kazuto Kozaka, Minoru Tanaka, Yasuni Nakanuma, Kenichi Harada. Diversity in cell differentiation, histology, phenotype and vasculature of mass‐forming intrahepatic cholangiocarcinomas. Histopathology 2021; 79(5) doi: 10.1111/his.14417
|
| 82 |
Jin Uk Choi, Shin Hwang, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Jae Seung Kim, Seung-Mo Hong. Diagnostic and prognostic impact of fluorodeoxyglucose-positron emission tomography in diagnosing intraductal papillary neoplasms of the bile duct of the liver. Annals of Surgical Treatment and Research 2022; 102(6) doi: 10.4174/astr.2022.102.6.335
|
| 83 |
Mechanisms and Therapy of Liver Cancer. Advances in Cancer Research 2021; 149 doi: 10.1016/bs.acr.2020.10.005
|
| 84 |
Gábor Lendvai, Tímea Szekerczés, Idikó Illyés, Réka Dóra, Endre Kontsek, Alíz Gógl, András Kiss, Klára Werling, Ilona Kovalszky, Zsuzsa Schaff, Katalin Borka. Cholangiocarcinoma: Classification, Histopathology and Molecular Carcinogenesis. Pathology & Oncology Research 2020; 26(1) doi: 10.1007/s12253-018-0491-8
|
| 85 |
Chaobo Chen, Leonard J. Nelson, Matías A. Ávila, Francisco Javier Cubero. Mitogen-Activated Protein Kinases (MAPKs) and Cholangiocarcinoma: The Missing Link. Cells 2019; 8(10) doi: 10.3390/cells8101172
|
| 86 |
Winnie A. Mar, Hing Kiu Chan, Surbhi B. Trivedi, Senta M. Berggruen. Imaging of Intrahepatic Cholangiocarcinoma. Seminars in Ultrasound, CT and MRI 2021; 42(4) doi: 10.1053/j.sult.2021.04.001
|
| 87 |
Nittaya Chamadol, Richard Syms, Vallop Laopaiboon, Julaluck Promsorn, Kulyada Eurboonyanun. Liver Fluke, Opisthorchis viverrini Related Cholangiocarcinoma. Recent Results in Cancer Research 2023; 219 doi: 10.1007/978-3-031-35166-2_6
|
| 88 |
Ruchi Sharma, Chandana Majee, Rupa Mazumder, Avijit Mazumder, Pankaj Kumar Tyagi, M. V. N. L. Chaitanya. Insight Into the Role of Alkaloids in the Different Signalling Pathways of Cholangiocarcinoma. Journal of Natural Remedies 2024; doi: 10.18311/jnr/2024/34661
|
| 89 |
Hong Ja Kim. Intrahepatic Cholangiocarcinoma: Evolving Concepts and Medical Treatment. The Korean Journal of Pancreas and Biliary Tract 2021; 26(1) doi: 10.15279/kpba.2021.26.1.33
|
| 90 |
Thomas Boerner, Esther Drill, Linda M. Pak, Bastien Nguyen, Carlie S. Sigel, Alexandre Doussot, Paul Shin, Debra A. Goldman, Mithat Gonen, Peter J. Allen, Vinod P. Balachandran, Andrea Cercek, James Harding, David B. Solit, Nikolaus Schultz, Ritika Kundra, Henry Walch, Michael I. D’Angelica, Ronald P. DeMatteo, Jeffrey Drebin, Nancy E. Kemeny, T. Peter Kingham, Amber L. Simpson, Jaclyn F. Hechtman, Efsevia Vakiani, Maeve A. Lowery, J.N.M. Ijzermans, S. Buettner, B. Groot Koerkamp, M. Doukas, Rohit Chandwani, William R. Jarnagin. Genetic Determinants of Outcome in Intrahepatic Cholangiocarcinoma. Hepatology 2021; 74(3) doi: 10.1002/hep.31829
|
| 91 |
Pankaj Gupta, Avinash Kambadakone, Bhawna Sirohi. Editorial: Role of imaging in biliary tract cancer: diagnosis, staging, response prediction and image-guided therapeutics. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1387531
|
| 92 |
|
| 93 |
Nathalie Guedj. Pathology of Cholangiocarcinomas. Current Oncology 2022; 30(1) doi: 10.3390/curroncol30010030
|
| 94 |
Jung Min Youn, Shin Hwang, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Seung-Mo Hong. Clinicopathological Features and Long-Term Outcomes of Intraductal Papillary Neoplasms of the Bile Duct of the Liver: Single-Institution Experience with 146 Patients. Journal of Gastrointestinal Surgery 2022; 26(7) doi: 10.1007/s11605-022-05268-2
|
| 95 |
Tian Tan, Shu-Ting Deng, Bing-Huo Wu, Qi Yang, Meng-Wan Wu, Hong Wu, Chen-Hui Cao, Chuan Xu. mRNA Vaccine - A New Cancer Treatment Strategy. Current Cancer Drug Targets 2023; 23(9) doi: 10.2174/1568009623666230222124424
|
| 96 |
Ken Nagata, Takahiro Einama, Akifumi Kimura, Michinori Murayama, Hiroteru Takeo, Makoto Nishikawa, Mayumi Hoshikawa, Takuji Noro, Sho Ogata, Suefumi Aosasa, Yoshiki Kajiwara, Eiji Shinto, Yoshihisa Yaguchi, Shuichi Hiraki, Hironori Tsujimoto, Kazuo Hase, Hideki Ueno, Junji Yamamoto. A case of intrahepatic cholangiocarcinoma that was difficult to diagnose prior to surgery: A case report. Oncology Letters 2018; doi: 10.3892/ol.2018.9666
|
| 97 |
Jing Jin, Han Suk Ryu, Kyoung Bun Lee, Ja-June Jang, Sang Hoon Ahn. High Expression of Protein Tyrosine Kinase 7 Significantly Associates with Invasiveness and Poor Prognosis in Intrahepatic Cholangiocarcinoma. PLoS ONE 2014; 9(2) doi: 10.1371/journal.pone.0090247
|
| 98 |
Chaiwat Tawarungruang, Narong Khuntikeo, Nittaya Chamadol, Vallop Laopaiboon, Jaruwan Thuanman, Kavin Thinkhamrop, Matthew Kelly, Bandit Thinkhamrop. Survival after surgery among patients with cholangiocarcinoma in Northeast Thailand according to anatomical and morphological classification. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08247-z
|
| 99 |
Jelena Djokic Kovač, Aleksandra Janković, Aleksandra Đikić-Rom, Nikica Grubor, Andrija Antić, Vladimir Dugalić. Imaging Spectrum of Intrahepatic Mass-Forming Cholangiocarcinoma and Its Mimickers: How to Differentiate Them Using MRI. Current Oncology 2022; 29(2) doi: 10.3390/curroncol29020061
|
| 100 |
Akira Watanabe, Hideki Suzuki, Norio Kubo, Kenichiro Araki, Tsutomu Kobayashi, Shigeru Sasaki, Wataru Wada, Hideo Arai, Kazuha Sakamoto, Shinji Sakurai, Hiroyuki Kuwano. An Oncocytic Variant of Intraductal Papillary Neoplasm of the Bile Duct that Formed a Giant Hepatic Cyst. Rare Tumors 2013; 5(3) doi: 10.4081/rt.2013.e30
|
| 101 |
|
| 102 |
Laura Rubbia-Brandt, Benoit Terris. Biliary Tract and Gallbladder Cancer. Medical Radiology 2014; doi: 10.1007/978-3-642-40558-7_4
|
| 103 |
Maryam Barsch, Elaine-Pashupati Dopfer, Anne Maria Schultheis, Michael Quante. Molecular Testing for Intrahepatic Cholangiocarcinoma: What, When, How?. Journal of Gastrointestinal Cancer 2026; 57(1) doi: 10.1007/s12029-026-01397-y
|
| 104 |
Shahrzad Azizi, Reza Kheirandiah, Masoud Sami. Slaughterhouse report of intrahepatic cholangiocarcinoma in a Holstein cow. Comparative Clinical Pathology 2016; 25(6) doi: 10.1007/s00580-016-2324-z
|
| 105 |
HIROYA IIDA, MASAKI HATA, AYAKO KAKUNO, HIROSHI HIRANO, KOJI YAMANEGI, NAOKO YAMADA, HIDEKI OHYAMA, NOBUYUKI TERADA, CHIAKI YASUI, NAOKI YAMANAKA, KEIJI NAKASHO. Expression of hepatocyte markers in mass-forming peripheral and periductal-infiltrating hilar intrahepatic cholangiocarcinomas. Oncology Letters 2011; 2(6) doi: 10.3892/ol.2011.405
|
| 106 |
Shogo Kobayashi, Hiroshi Wada, Akira Tomokuni, Hidenori Takahashi, Kunihito Gotoh, Masato Sakon, Masaki Mori, Yuichiro Doki, Hidetoshi Eguchi. Invasion category-oriented lymph node metastases of cholangiocarcinoma and the prognostic impact. Langenbeck's Archives of Surgery 2020; 405(7) doi: 10.1007/s00423-020-01955-3
|
| 107 |
Susumu Ohfuji. Cholangiocarcinoma of possibly hepatic progenitor cell origin in a cow. Veterinary Quarterly 2012; 32(3-4) doi: 10.1080/01652176.2012.749363
|
| 108 |
Paul J. Brindley, Melinda Bachini, Sumera I. Ilyas, Shahid A. Khan, Alex Loukas, Alphonse E. Sirica, Bin Tean Teh, Sopit Wongkham, Gregory J. Gores. Cholangiocarcinoma. Nature Reviews Disease Primers 2021; 7(1) doi: 10.1038/s41572-021-00300-2
|
| 109 |
Myeong-Jin Kim, Hyungjin Rhee, Ha Young Woo. A dichotomous imaging classification for cholangiocarcinomas based on new histologic concepts. European Journal of Radiology 2019; 113 doi: 10.1016/j.ejrad.2019.02.025
|
| 110 |
Yanhang Gao, Yanqing Li, Xiaowen Liu, Tong Zhang, Ge Yu, Yang Wang, Ying Shi, Xiumei Chi, Xiaomei Wang, Xiuzhu Gao, Ruihong Wu, Yingyu Zhang, Lei Hang, Shijuan Sun, Yazhe Guan, Ying Xu, Jing Meng, Xu Liu, Chang Jiang, Heming Ma, Liting Luo, Qi Yan, Xin Yin, Fei Peng, Yixiao Zhi, Weige Qu, Xia Zhang, Tianqi Ren, Lili Liu, Jinming Zhao, Feiyu Zhang, Adila Yakepu, Yu Pan, Hongqin Xu, Junqi Niu. High prevalence of Clonorchis sinensis infections and coinfection with hepatitis virus in riverside villages in northeast China. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-68684-x
|
| 111 |
Jeong Hee Yoon, Jeong Min Lee. Can MRI Features Predict Prognosis in Mass-forming Intrahepatic Cholangiocarcinoma?. Radiology 2019; 290(3) doi: 10.1148/radiol.2018182775
|
| 112 |
Gian Piero Guerrini, Giuseppe Esposito, Giuseppe Tarantino, Valentina Serra, Tiziana Olivieri, Barbara Catellani, Giacomo Assirati, Cristiano Guidetti, Roberto Ballarin, Paolo Magistri, Fabrizio Di Benedetto. Laparoscopic versus open liver resection for intrahepatic cholangiocarcinoma: the first meta-analysis. Langenbeck's Archives of Surgery 2020; 405(3) doi: 10.1007/s00423-020-01877-0
|
| 113 |
Elham Karimi, Niloufar Sadat Kalaki, Mahnaz Shavandi, Fargol Mahlouji, Abed El Hasan Haidar, Aria Abedi Asl, Fahimeh Safarnezhad Tameshkel, Farhad Zamani, Mohammad Hadi Karbalaie Niya. Key hub genes and pathways associated with HCV-related hepatocellular carcinoma as potential diagnostic biomarkers. Journal of Genetic Engineering and Biotechnology 2026; 24(3) doi: 10.1016/j.jgeb.2026.100721
|
| 114 |
Sungeun Park, Youngeun Lee, Haeryoung Kim, Mi Hye Yu, Eun Sun Lee, Jeong Hee Yoon, Ijin Joo, Jeong Min Lee. Subtype Classification of Intrahepatic Cholangiocarcinoma Using Liver MR Imaging Features and Its Prognostic Value. Liver Cancer 2022; 11(3) doi: 10.1159/000521747
|
| 115 |
Maria El Homsi, Ahmad Alkhasawneh, Hina Arif-Tiwari, Ferenc Czeyda-Pommersheim, Hala Khasawneh, Andrea Siobhan Kierans, Raj Mohan Paspulati, Charanjeet Singh. Classification of intrahepatic cholangiocarcinoma. Abdominal Radiology 2024; 50(6) doi: 10.1007/s00261-024-04732-8
|
| 116 |
Hao Cai, Wen-Tao Kong, Chao-Bo Chen, Guo-Ming Shi, Cheng Huang, Ying-Hao Shen, Hui-Chuan Sun. Cholelithiasis and the risk of intrahepatic cholangiocarcinoma: a meta-analysis of observational studies. BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1870-0
|
| 117 |
Nieun Seo, Do Young Kim, Jin-Young Choi. Cross-Sectional Imaging of Intrahepatic Cholangiocarcinoma: Development, Growth, Spread, and Prognosis. American Journal of Roentgenology 2017; 209(2) doi: 10.2214/AJR.16.16923
|
| 118 |
Hsing-Ju Wu, Pei-Yi Chu. Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications. International Journal of Molecular Sciences 2019; 20(17) doi: 10.3390/ijms20174154
|
| 119 |
Taek Chung, Hyungjin Rhee, Hyo Sup Shim, Jeong Eun Yoo, Gi Hong Choi, Haeryoung Kim, Young Nyun Park. Genetic, Clinicopathological, and Radiological Features of Intrahepatic Cholangiocarcinoma with Ductal Plate Malformation Pattern. Gut and Liver 2022; 16(4) doi: 10.5009/gnl210174
|
| 120 |
Keisaku Sato, Shannon Glaser, Domenico Alvaro, Fanyin Meng, Heather Francis, Gianfranco Alpini. Cholangiocarcinoma: novel therapeutic targets. Expert Opinion on Therapeutic Targets 2020; 24(4) doi: 10.1080/14728222.2020.1733528
|
| 121 |
Anne R.J. Péporté, Wieland H. Sommer, Konstantin Nikolaou, Maximilian F. Reiser, Christoph J. Zech. Imaging features of intrahepatic cholangiocarcinoma in Gd-EOB-DTPA-enhanced MRI. European Journal of Radiology 2013; 82(3) doi: 10.1016/j.ejrad.2012.10.010
|
| 122 |
Alphonse E. Sirica, Roberto J. Groszmann, Yasuko Iwakiri, Tamar H. Taddei. Notching up on the cellular origins of intrahepatic cholangiocarcinoma. Hepatology 2013; 57(4) doi: 10.1002/hep.26313
|
| 123 |
Mariano M. Volpacchio. Invited Commentary: Early Detection of Biliary Malignancies: Are We There Yet?. RadioGraphics 2022; 42(5) doi: 10.1148/rg.220003
|
| 124 |
Mohd Elmugtaba Ibrahim, Kerolos Abadeer, Qihui (Jim) Zhai, Aziza Nassar. Primary Hepatic Neuroendocrine Tumor with Unusual Thyroid Follicular-Like Morphologic Characteristics. Case Reports in Pathology 2017; 2017 doi: 10.1155/2017/7931975
|
| 125 |
Yeon Seung Chung, Youngsic Jeon, Jeong Eun Yoo, Taek Chung, Hyang Joo Ryu, Hyunki Kim, Hyungjin Rhee, Young Nyun Park. Albumin, filamin-A and cytokeratin 19 help distinguish intrahepatic cholangiocarcinoma from extrahepatic adenocarcinoma. Hepatology International 2023; 17(1) doi: 10.1007/s12072-022-10428-2
|
| 126 |
Seorin Jeong, Kyoungbun Lee, Xianyu Wen, Younghoon Kim, Nam-Yun Cho, Ja-June Jang, Gyeong Hoon Kang. Tumoral LINE-1 hypomethylation is associated with poor survival of patients with intrahepatic cholangiocarcinoma. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3595-8
|
| 127 |
Kei Hagiwara, Kenichiro Araki, Takahiro Yamanaka, Norihiro Ishii, Takamichi Igarashi, Akira Watanabe, Norio Kubo, Norifumi Harimoto, Hiroyuki Kuwano, Sumito Nobusawa, Shinichi Aishima, Ken Shirabe. Resected primary mucinous cholangiocarcinoma of the liver. Surgical Case Reports 2018; 4(1) doi: 10.1186/s40792-018-0450-3
|
| 128 |
Yuko Yoshida, Tetsuo Ajiki, Taro Okazaki, Taku Matsumoto, Sae Murakami, Kenta Shinozaki, Takumi Fukumoto, Ayako Tomono, Shigeo Hara, Yonson Ku. Intrahepatic Cholangiocarcinoma with Superficial Spread Arising after Long-term Follow-up of Hepatolithiasis. The Japanese Journal of Gastroenterological Surgery 2014; 47(12) doi: 10.5833/jjgs.2014.0078
|
| 129 |
Takeshi YAGI, Mitsutaka JINBO, Naomasa UESUGI, Satoshi SAITO, Tsuyoshi TAKAHASHI, Hidenori GOHRA. A case of mucin-producing cholangiocarcinoma originating from an intraductal papillary neoplasm of the bile duct without dilatation of the intrahepatic bile duct. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 2013; 74(1) doi: 10.3919/jjsa.74.196
|
| 130 |
Xin Xu. Diagnosis of hilar cholangiocarcinoma using intravoxel incoherent motion diffusion-weighted magnetic resonance imaging. Abdominal Radiology 2021; 46(7) doi: 10.1007/s00261-021-02997-x
|
| 131 |
Dina Ioffe, Pooja Phull, Efrat Dotan. Optimal Management of Patients with Advanced or Metastatic Cholangiocarcinoma: An Evidence-Based Review. Cancer Management and Research 2021; doi: 10.2147/CMAR.S276104
|
| 132 |
Wan-Joon Kim, Shin Hwang, Yong-Joo Lee, Ki-Hun Kim, Kwang-Min Park, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Gil-Chun Park, Myeong-Hwan Kim, Sung-Koo Lee, Dong Wan Seo, Do Hyun Park, Sang Soo Lee, Sung-Gyu Lee. Clinicopathological Features and Long-Term Outcomes of Intraductal Papillary Neoplasms of the Intrahepatic Bile Duct. Journal of Gastrointestinal Surgery 2016; 20(7) doi: 10.1007/s11605-016-3103-5
|
| 133 |
Derek B. Allison, David Borzik, Qing Kay Li. Atlas of Non-Gynecologic Cytology. 2018; doi: 10.1007/978-3-319-89674-8_7
|
| 134 |
Roberto Troisi, Roberto Montalti, Alex Gordon-Weeks, Marcello Di Martino, Gianluca Rompianesi. Liquid biopsy in cholangiocarcinoma: Current status and future perspectives. World Journal of Gastrointestinal Oncology 2021; 13(5): 332-350 doi: 10.4251/wjgo.v13.i5.332
|
| 135 |
Md. Shimul Bhuia, Raihan Chowdhury, Meher Afroz, Md. Showkot Akbor, Md. Sakib Al Hasan, Jannatul Ferdous, Rubel Hasan, Marcus Vinícius Oliveira Barros de Alencar, Mohammad S. Mubarak, Muhammad Torequl Islam. Therapeutic Efficacy Studies on the Monoterpenoid Hinokitiol in the Treatment of Different Types of Cancer. Chemistry & Biodiversity 2025; 22(5) doi: 10.1002/cbdv.202401904
|
| 136 |
Vaidehi Avadhani, Cynthia Cohen, Momin T. Siddiqui, Alyssa Krasinskas. A Subset of Intrahepatic Cholangiocarcinomas Express Albumin RNA as Detected by In Situ Hybridization. Applied Immunohistochemistry & Molecular Morphology 2021; 29(3) doi: 10.1097/PAI.0000000000000882
|
| 137 |
Laurence P. Diggs, Benjamin Ruf, Chi Ma, Bernd Heinrich, Linda Cui, Qianfei Zhang, John C. McVey, Simon Wabitsch, Sophia Heinrich, Umberto Rosato, Walter Lai, Varun Subramanyam, Thomas Longerich, Sven H. Loosen, Tom Luedde, Ulf Peter Neumann, Sabina Desar, David Kleiner, Gregory Gores, Xin Wei Wang, Tim F. Greten. CD40-mediated immune cell activation enhances response to anti-PD-1 in murine intrahepatic cholangiocarcinoma. Journal of Hepatology 2021; 74(5) doi: 10.1016/j.jhep.2020.11.037
|
| 138 |
Yuemeng Jia, Dawei Sun, Jackson A. Weir, Xugeng Liu, Andrew J.C. Russell, YeEun Kim, Nicholas Thom, Giovanni Marrero, Vipin Kumar, Fei Chen, Fernando D. Camargo. SPACE-seq integrates spatial transcriptomics and lineage tracing in native tissues. Cell Stem Cell 2026; doi: 10.1016/j.stem.2026.05.017
|
| 139 |
Ju Gang Nam, Jeong Min Lee, Ijin Joo, Su Joa Ahn, Jin Young Park, Kyoung Bun Lee, Joon Koo Han. Intrahepatic Mass-Forming Cholangiocarcinoma: Relationship Between Computed Tomography Characteristics and Histological Subtypes. Journal of Computer Assisted Tomography 2018; 42(3) doi: 10.1097/RCT.0000000000000695
|
| 140 |
Tushar Patel. New insights into the molecular pathogenesis of intrahepatic cholangiocarcinoma. Journal of Gastroenterology 2014; 49(2) doi: 10.1007/s00535-013-0894-y
|
| 141 |
Hodaka Oki, Yoshiko Hayashida, Tomohiro Namimoto, Takatoshi Aoki, Yukunori Korogi, Yasuyuki Yamashita. Usefulness of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance cholangiography for detecting mucin retention in bile ducts: a rare intraductal papillary mucinous neoplasm of the bile duct. Japanese Journal of Radiology 2011; 29(8) doi: 10.1007/s11604-011-0593-7
|
| 142 |
Irai S. Oliveira, Aoife Kilcoyne, Jamie M. Everett, Mari Mino-Kenudson, Mukesh G. Harisinghani, Karthik Ganesan. Cholangiocarcinoma: classification, diagnosis, staging, imaging features, and management. Abdominal Radiology 2017; 42(6) doi: 10.1007/s00261-017-1094-7
|
| 143 |
Jae Hyun Kim, Jeong Hee Yoon, Ijin Joo, Jeong Min Lee. Evaluation of Primary Liver Cancers Using Hepatocyte‐Specific Contrast‐Enhanced MRI: Pitfalls and Potential Tips. Journal of Magnetic Resonance Imaging 2021; 53(3) doi: 10.1002/jmri.27213
|
| 144 |
Ahmad Al Nakshabandi, Jeffrey H Lee. Contemporary advances in the endoscopic management of cholangiocarcinoma: a review of accomplished milestones and prospective opportunities. Expert Review of Gastroenterology & Hepatology 2023; 17(2) doi: 10.1080/17474124.2023.2170875
|
| 145 |
Nimish Thakral, Teresita Gonzalez, Olger Nano, Sang-Ha Shin, Shenae Samuels, Atif Hussein. Cirrhosis in intrahepatic cholangiocarcinoma: prognostic importance and impact on survival. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02710-w
|
| 146 |
Andreas W. Berger, Lukas Perkhofer, Thomas J. Ettrich. Aktuelle systemische Therapie beim cholangiozellulären Karzinom. Die Onkologie 2023; 29(9) doi: 10.1007/s00761-023-01373-2
|
| 147 |
Engin Gürlevik, Bettina Fleischmann-Mundt, Nina Armbrecht, Thomas Longerich, Norman Woller, Arnold Kloos, Dirk Hoffmann, Axel Schambach, Thomas C. Wirth, Michael P. Manns, Lars Zender, Stefan Kubicka, Florian Kühnel. Adjuvant Gemcitabine Therapy Improves Survival in A Locally Induced, R0-Resectable Model of Metastatic Intrahepatic Cholangiocarcinoma. Hepatology 2013; 58(3) doi: 10.1002/hep.26468
|
| 148 |
Taek Chung, Young Nyun Park. Up-to-Date Pathologic Classification and Molecular Characteristics of Intrahepatic Cholangiocarcinoma. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.857140
|
| 149 |
Domenico Alvaro, Vincenzo Cardinale. Biliary Tract and Gallbladder Cancer. Medical Radiology 2014; doi: 10.1007/978-3-642-40558-7_7
|
| 150 |
Fatmagül Kuşku Çabuk, Nuray Başsüllü, İlknur Türkmen, Murat Dayangaç, Murat Akyıldız, Yıldıray Yüzer, Yaman Tokat, Gülen Bülbül Doğusoy. The prognostic relationship between histopathological and immunohistochemical features of hepatocellular carcinoma, intrahepatic cholangiocarcinoma and mixed type. Polish Journal of Pathology 2020; 71(2) doi: 10.5114/pjp.2020.97015
|
| 151 |
Loic Verlingue, Antoine Hollebecque, Valérie Boige, Michel Ducreux, David Malka, Charles Ferté. Matching genomic molecular aberrations with molecular targeted agents: Are biliary tract cancers an ideal playground?. European Journal of Cancer 2017; 81 doi: 10.1016/j.ejca.2017.05.006
|
| 152 |
Silvestre Vicent, Ruby Lieshout, Anna Saborowski, Monique M. A. Verstegen, Chiara Raggi, Stefania Recalcati, Pietro Invernizzi, Luc J. W. van der Laan, Domenico Alvaro, Diego F. Calvisi, Vincenzo Cardinale. Experimental models to unravel the molecular pathogenesis, cell of origin and stem cell properties of cholangiocarcinoma. Liver International 2019; 39(S1) doi: 10.1111/liv.14094
|
| 153 |
Jia‐Huei Tsai, Jau‐Yu Liau, Chang‐Tsu Yuan, Mei‐Ling Cheng, Ray‐Hwang Yuan, Yung‐Ming Jeng. RNF43 mutation frequently occurs with GNAS mutation and mucin hypersecretion in intraductal papillary neoplasms of the bile duct. Histopathology 2017; 70(5) doi: 10.1111/his.13125
|
| 154 |
Alyssa M. Krasinskas. Cholangiocarcinoma. Surgical Pathology Clinics 2018; 11(2) doi: 10.1016/j.path.2018.02.005
|
| 155 |
Jian Yang, Wentao Wang, Lunan Yan. The clinicopathological features of intraductal papillary neoplasms of the bile duct in a Chinese population. Digestive and Liver Disease 2012; 44(3) doi: 10.1016/j.dld.2011.08.014
|
| 156 |
M. G. Efanov, N. S. Karnaukhov, N. N. Britskaia, N. V. Makarenko, P. V. Tarakanov, D. V. Fisenko, V. V. Tsvirkun. Intrahepatic cholangiocarcinoma: correlation between histological subtype and survival. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery 2025; 30(1) doi: 10.16931/1995-5464.2025-1-31-38
|
| 157 |
Chihiro Gandou, Kenichi Harada, Yasunori Sato, Saya Igarashi, Motoko Sasaki, Hiroko Ikeda, Yasuni Nakanuma. Hilar cholangiocarcinoma and pancreatic ductal adenocarcinoma share similar histopathologies, immunophenotypes, and development-related molecules. Human Pathology 2013; 44(5) doi: 10.1016/j.humpath.2012.08.004
|
| 158 |
Marut Laohaviroj, Yaovalux Chamgramol, Chawalit Pairojkul, Jason Mulvenna, Banchob Sripa. Clinicopathological Significance of Osteopontin in Cholangiocarcinoma Cases. Asian Pacific Journal of Cancer Prevention 2016; 17(1) doi: 10.7314/APJCP.2016.17.1.201
|
| 159 |
Scott M. Thompson, Lorena Marcano-Bonilla, Taofic Mounajjed, Benjamin R. Kipp, Julie K. Heimbach, Christopher L. Hallemeier, Mitesh J. Borad, Lewis R. Roberts. Evaluation and Management of Liver Masses. 2020; doi: 10.1007/978-3-030-46699-2_2
|
| 160 |
Aleksey V. Dedov, Yu. N. Sikorskaya, M. R. Bekov, A. V. Savishchev. Cholangiocellular carcinoma associated with liver cirrhosis and recurrent esophageal variceal bleeding: a clinical case. Surgery and Oncology 2026; 16(1) doi: 10.17650/2949-5857-2026-16-1-108-115
|
| 161 |
Andrea S. Kierans, James Costello, Aliya Qayyum, Bachir Taouli, Sudhakar K. Venkatesh, Jeong Hee Yoon, Maria A. Bali, Candice W. Bolan, Jeong Min Lee, Robert M. Marks, Maria El Homsi, Frank H. Miller. Imaging cholangiocarcinoma: CT and MRI techniques. Abdominal Radiology 2024; 50(1) doi: 10.1007/s00261-024-04216-9
|
| 162 |
Stefania Cannito, Chiara Milani, Andrea Cappon, Maurizio Parola, Mario Strazzabosco, Massimiliano Cadamuro. Fibroinflammatory Liver Injuries as Preneoplastic Condition in Cholangiopathies. International Journal of Molecular Sciences 2018; 19(12) doi: 10.3390/ijms19123875
|
| 163 |
Ammara Naveed, Haseeb Haider Zia, Aasim Yusuf, Ghias-un-Nabi Tayyab, Amjad Salamat, Abdullah Saeed, Mohammad Salih, Sohail Rashid, Kamran Rashid, Ahmad Karim Malik, Nasir Hassan Luck, Amer Latif, Muhammad Yasir Khan, Muhammad Shoaib Khan, Aman Nawaz Khan, Adnan Abdul Jabbar, Syed Mujahid Hassan, Siraj Haider, Jahanzaib Haider, Faisal Hanif, Javed Iqbal Farooqi, Abdul Wahab Dogar, Osama Tariq Butt, Amna Subhan Butt, Tariq Ali Bangash, Abu Bakar Hafeez Bhatti, Zeba Aziz, Muhammad Azeemuddin, Usman Iqbal Aujla, Muhammad Atique, Irfan Ahmed, Zaigham Abbas, Faisal Saud Dar. National guidelines for the diagnosis and treatment of hilar cholangiocarcinoma. World Journal of Gastroenterology 2024; 30(9): 1018-1042 doi: 10.3748/wjg.v30.i9.1018
|
| 164 |
A. E. Kovshirina, O. S. Fedorova, Y. V. Kovshirina, S. V. Onishchenko, S. S. Taslicki, L. L. Katanakhova, A. V. Chizhikov, I. A. Tataurov, L. M. Ororodova. Association between cholangiocarcinoma and liver flukes: review of epidemiological studies. Bulletin of Siberian Medicine 2020; 19(1) doi: 10.20538/1682-0363-2020-1-150-159
|
| 165 |
Zihan Li, Hiep Nguyen Canh, Kenta Takahashi, Dong Le Thanh, Quynh Nguyen Thi, Rui Yang, Kaori Yoshimura, Yasunori Sato, Khuyen Nguyen Thi, Hiroki Nakata, Hiroko Ikeda, Kazuto Kozaka, Satoshi Kobayashi, Shintaro Yagi, Kenichi Harada. Histopathological growth pattern and vessel co-option in intrahepatic cholangiocarcinoma. Medical Molecular Morphology 2024; 57(3) doi: 10.1007/s00795-024-00392-1
|
| 166 |
Takumi Kawaguchi, Ryohei Kaji, Hiroyuki Horiuchi, Tomotake Shirono, Yusuke Ishida, Yoshinobu Okabe, Minoru Itou, Keiichi Mitsuyama, Jun Akiba, Osamu Nakashima, Hirohisa Yano, Masayoshi Kage, Masaru Harada, Shotaro Sakisaka, Michio Sata. Development of intrahepatic cholangiocarcinoma after a 14‐year follow‐up of a patient with primary sclerosing cholangitis and ulcerative colitis. Hepatology Research 2011; 41(12) doi: 10.1111/j.1872-034X.2011.00875.x
|
| 167 |
Xiaoping Yin, Zhiyan Lu, Wanjun Xia, Yongmei Li, Liping Liu, Yu Zhang, Liyong Zhuo, Yufang Zhao, Jianing Wang, Lihong Xing, Xinjiang Liu, Xi Ma. Radiology of Hepatobiliary Diseases. 2025; doi: 10.1007/978-981-97-2985-2_64
|
| 168 |
Ayaka Mitsui, Minoru Esaki, Satoshi Nara, Yasuhito Arai, Hiromi Nakamura, Tatsuhiro Shibata, Daisuke Ban, Takahiro Mizui, Nobuyoshi Hiraoka. Bile duct tumor thrombus (intraductal polypoid growth)–positive intrahepatic cholangiocarcinoma: clinicopathologic and genomic analysis. The Journal of Pathology 2026; 269(1) doi: 10.1002/path.70038
|
| 169 |
Vincenza Granata, Roberta Fusco, Andrea Belli, Valentina Borzillo, Pierpaolo Palumbo, Federico Bruno, Roberta Grassi, Alessandro Ottaiano, Guglielmo Nasti, Vincenzo Pilone, Antonella Petrillo, Francesco Izzo. Conventional, functional and radiomics assessment for intrahepatic cholangiocarcinoma. Infectious Agents and Cancer 2022; 17(1) doi: 10.1186/s13027-022-00429-z
|
| 170 |
Fredy Chablé-Montero, Amy Shah BS, Daniel Montante-Montes de Oca, Arturo Ángeles-Ángeles, Donald E. Henson, Jorge Albores-Saavedra. Thyroid-like cholangiocarcinoma of the liver: an unusual morphologic variant with follicular, trabecular and insular patterns. Annals of Hepatology 2012; 11(6) doi: 10.1016/S1665-2681(19)31427-9
|
| 171 |
Michael J Passeri, Maria R Baimas-George, Jesse K Sulzer, David A Iannitti, John B Martinie, Erin H Baker, Lee M Ocuin, Dionisios Vrochides. Prognostic impact of the Bismuth-Corlette classification: Higher rates of local unresectability in stage IIIb hilar cholangiocarcinoma. Hepatobiliary & Pancreatic Diseases International 2020; 19(2) doi: 10.1016/j.hbpd.2020.02.001
|
| 172 |
Mami Hamaoka, Kazuto Kozaka, Osamu Matsui, Takahiro Komori, Takashi Matsubara, Norihide Yoneda, Kotaro Yoshida, Dai Inoue, Azusa Kitao, Wataru Koda, Toshifumi Gabata, Satoshi Kobayashi. Early detection of intrahepatic cholangiocarcinoma. Japanese Journal of Radiology 2019; 37(10) doi: 10.1007/s11604-019-00860-0
|
| 173 |
Sungeun Park, Jeong Min Lee, Junghoan Park, Jihyuk Lee, Jae Seok Bae, Jae Hyun Kim, Ijin Joo. Volumetric CT Texture Analysis of Intrahepatic Mass-Forming Cholangiocarcinoma for the Prediction of Postoperative Outcomes: Fully Automatic Tumor Segmentation Versus Semi-Automatic Segmentation. Korean Journal of Radiology 2021; 22(11) doi: 10.3348/kjr.2021.0055
|
| 174 |
Saya Igarashi, Takashi Matsubara, Kenichi Harada, Hiroko Ikeda, Yasunori Sato, Motoko Sasaki, Osamu Matsui, Yasuni Nakanuma. Bile duct expression of pancreatic and duodenal homeobox 1 in perihilar cholangiocarcinogenesis. Histopathology 2012; 61(2) doi: 10.1111/j.1365-2559.2012.04218.x
|
| 175 |
Shinichi Aishima, Yoshinao Oda. Pathogenesis and classification of intrahepatic cholangiocarcinoma: different characters of perihilar large duct type versus peripheral small duct type. Journal of Hepato-Biliary-Pancreatic Sciences 2015; 22(2) doi: 10.1002/jhbp.154
|
| 176 |
Charilaos Papafragkakis, Jeffrey Lee. Comprehensive management of cholangiocarcinoma: Part I. Diagnosis. International Journal of Gastrointestinal Intervention 2017; 6(2) doi: 10.18528/gii1500341
|
| 177 |
Tomohiro Shimoda, Hiroshi Yoshida, Atsushi Hirakata, Hiroshi Makino, Tadashi Yokoyama, Hiroshi Maruyama, Junji Ueda, Masataka Tanno, Zenya Naito, Eiji Uchida. Surgical Resection of Cystic Intraductal Papillary Adenocarcinoma of the Bile Duct: Report of a Case. Journal of Nippon Medical School 2013; 80(3) doi: 10.1272/jnms.80.234
|
| 178 |
Jae Hoon Lim, Kee-Taek Jang, Jung Hoon Kim. Neoplasms of the Biliary Tract. 2021; doi: 10.1007/978-981-15-6659-2_5
|
| 179 |
Serena Langella, Serena Armentano, Nadia Russolillo, Andrea-Pierre Luzzi, Andrea Pierluigi Fontana, Lorenzo Daniele, Alessandro Ferrero. Colorectal metastases with intrabiliary growth: incidence, treatment, and outcomes. Updates in Surgery 2024; 76(2) doi: 10.1007/s13304-024-01752-3
|
| 180 |
Taro Mashiko, Joaquim Carreras, Toshihito Ogasawara, Yoshihito Masuoka, Shigenori Ei, Shinichiro Takahashi, Takakiyo Nomura, Masaki Mori, Kazuo Koyanagi, Seiichiro Yamamoto, Naoya Nakamura, Toshio Nakagohri. Intrahepatic cholangiocarcinoma with arterial phase hyperenhancement and specialized tumor microenvironment associated with good prognosis after radical resection: A single-center retrospective study. Surgery 2024; 176(2) doi: 10.1016/j.surg.2024.03.024
|
| 181 |
So Yeon Kim. Preoperative Radiologic Evaluation of Cholangiocarcinoma. The Korean Journal of Gastroenterology 2017; 69(3) doi: 10.4166/kjg.2017.69.3.159
|
| 182 |
Antonio Cigliano, Jingxiao Wang, Xin Chen, Diego F. Calvisi. Role of the Notch signaling in cholangiocarcinoma. Expert Opinion on Therapeutic Targets 2017; 21(5) doi: 10.1080/14728222.2017.1310842
|
| 183 |
Hayat Khizar, Yufei Hu, Yanhua Wu, Jianfeng Yang. The role and implication of autophagy in cholangiocarcinoma. Cell Death Discovery 2023; 9(1) doi: 10.1038/s41420-023-01631-7
|
| 184 |
Lionel A. Kankeu Fonkoua, Pedro Luiz Serrano Uson Junior, Kabir Mody, Amit Mahipal, Mitesh J. Borad, Lewis R. Roberts. Novel and emerging targets for cholangiocarcinoma progression: therapeutic implications. Expert Opinion on Therapeutic Targets 2022; 26(1) doi: 10.1080/14728222.2022.2029412
|
| 185 |
Yasuni Nakanuma, Akemi Tsutsui, Xiang Shan Ren, Kenichi Harada, Yasunori Sato, Motoko Sasaki. What Are the Precursor and Early Lesions of Peripheral Intrahepatic Cholangiocarcinoma?. International Journal of Hepatology 2014; 2014 doi: 10.1155/2014/805973
|
| 186 |
Petia Jeliazkova, Simone Jörs, Jens T. Siveke, Fabian Geisler. On the role of notch1 and adult hepatocytes in murine intrahepatic cholangiocarcinoma development. Hepatology 2013; 58(5) doi: 10.1002/hep.26410
|
| 187 |
Keita Kai, Yasushi Ide, Atsushi Miyoshi, Masanori Masuda, Takao Ide, Kenji Kitahara, Hiroyuki Irie, Junko Nakajima, Hirokazu Noshiro, Osamu Tokunaga. A case of mucinous cholangiocarcinoma showing features of hepatocellular carcinoma. Pathology International 2013; 63(8) doi: 10.1111/pin.12081
|
| 188 |
Ignacio Fuente, Marcos Gonzalez, Martin de Santibañes, Juan Pekolj, Oscar Mazza, Eduardo de Santibañes, Rodrigo Sanchez Claria. Intraductal Papillary Neoplasm of the Bile Duct (IPNB): Case Report and Literature Review of a Challenging Disease to Diagnose. Journal of Gastrointestinal Cancer 2019; 50(3) doi: 10.1007/s12029-018-0057-8
|
| 189 |
Marco Massani, Tommaso Stecca, Bruno Pauletti, Gianpaolo Marte, Cesare Ruffolo, Luca Bonariol, Nicolo’ Bassi. Topics in the Surgery of the Biliary Tree. 2018; doi: 10.5772/intechopen.75516
|
| 190 |
Miaoyan Wei, Lisheng Lü, Peiyi Lin, Zhisheng Chen, Zhiwei Quan, Zhaohui Tang. Multiple cellular origins and molecular evolution of intrahepatic cholangiocarcinoma. Cancer Letters 2016; 379(2) doi: 10.1016/j.canlet.2016.02.038
|
| 191 |
Guido Carpino, Vincenzo Cardinale, Paolo Onori, Antonio Franchitto, Pasquale Bartolomeo Berloco, Massimo Rossi, Yunfang Wang, Rossella Semeraro, Maurizio Anceschi, Roberto Brunelli, Domenico Alvaro, Lola M. Reid, Eugenio Gaudio. Biliary tree stem/progenitor cells in glands of extrahepatic and intraheptic bile ducts: an anatomical in situ study yielding evidence of maturational lineages. Journal of Anatomy 2012; 220(2) doi: 10.1111/j.1469-7580.2011.01462.x
|
| 192 |
Jun Ma, Jinfeng Feng, Xiang Zhou. Long non-coding RNA HAGLROS regulates lipid metabolism reprogramming in intrahepatic cholangiocarcinoma via the mTOR signaling pathway. Experimental and Molecular Pathology 2020; 115 doi: 10.1016/j.yexmp.2020.104466
|
| 193 |
Xunhao Zhu, Qingqiang Ni, Qianchang Wang, Chaoqun Ma, Faji Yang, Hengjun Gao, Huaqiang Zhu, Xu Zhou, Hong Chang, Jun Lu, Fangfeng Liu. Intraductal papillary mucinous neoplasm of the biliary tract in the caudate lobe of the liver: a case report and literature review. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1114514
|
| 194 |
Kahan Mehta, Samir Mehta, Maurya Joshi, Hareesha R. Bharadwaj, Ghanshyam Ardeshana, Pearl O. Tenkorang. Challenging diagnosis of sarcomatoid hepatic mesothelioma: a case report with review of literature. Annals of Medicine & Surgery 2023; 85(10) doi: 10.1097/MS9.0000000000001148
|
| 195 |
Raymond Gong, Zongming E. Chen, Karen Matsukuma. Morphologic and immunohistochemical characterization of small and large duct cholangiocarcinomas in a Western cohort: A panel of pCEA, CRP, N-cadherin, and albumin in situ hybridization aids in subclassification. Annals of Diagnostic Pathology 2025; 75 doi: 10.1016/j.anndiagpath.2025.152437
|
| 196 |
Ijin Joo, Jeong Min Lee, Jeong Hee Yoon. Imaging Diagnosis of Intrahepatic and Perihilar Cholangiocarcinoma: Recent Advances and Challenges. Radiology 2018; 288(1) doi: 10.1148/radiol.2018171187
|
| 197 |
Benedetta Artegiani, Lisa van Voorthuijsen, Rik G.H. Lindeboom, Daniëlle Seinstra, Inha Heo, Pablo Tapia, Carmen López-Iglesias, Daniel Postrach, Talya Dayton, Rurika Oka, Huili Hu, Ruben van Boxtel, Johan H. van Es, Johan Offerhaus, Peter J. Peters, Jacco van Rheenen, Michiel Vermeulen, Hans Clevers. Probing the Tumor Suppressor Function of BAP1 in CRISPR-Engineered Human Liver Organoids. Cell Stem Cell 2019; 24(6) doi: 10.1016/j.stem.2019.04.017
|
| 198 |
Taotao Zhou, Robert Mahn, Christian Möhring, Farsaneh Sadeghlar, Carsten Meyer, Marieta Toma, Barbara Kreppel, Markus Essler, Tim Glowka, Hanno Matthaei, Jörg C. Kalff, Christian P. Strassburg, Maria A. Gonzalez-Carmona. Case Report: Sustained complete remission on combination therapy with olaparib and pembrolizumab in BRCA2-mutated and PD-L1-positive metastatic cholangiocarcinoma after platinum derivate. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.933943
|
| 199 |
Fabio Bagante, Gaya Spolverato, Katiuscha Merath, Matthew Weiss, Sorin Alexandrescu, Hugo P. Marques, Luca Aldrighetti, Shishir K. Maithel, Carlo Pulitano, Todd W. Bauer, Feng Shen, George A. Poultsides, Olivier Soubrane, Guillaume Martel, B. Groot Koerkamp, Alfredo Guglielmi, Itaru Endo, Timothy M. Pawlik. Intrahepatic cholangiocarcinoma tumor burden: A classification and regression tree model to define prognostic groups after resection. Surgery 2019; 166(6) doi: 10.1016/j.surg.2019.06.005
|
| 200 |
Veronika Brychtova, Vita Zampachova, Roman Hrstka, Pavel Fabian, Jiri Novak, Marketa Hermanova, Borivoj Vojtesek. Differential expression of anterior gradient protein 3 in intrahepatic cholangiocarcinoma and hepatocellular carcinoma. Experimental and Molecular Pathology 2014; 96(3) doi: 10.1016/j.yexmp.2014.04.002
|
| 201 |
Hyungjin Rhee, Sang Hyun Choi, Ji Hoon Park, Eun‐Suk Cho, Suk‐Keu Yeom, Sumi Park, Kyunghwa Han, Seung Soo Lee, Mi‐Suk Park. Preoperative magnetic resonance imaging‐based prognostic model for mass‐forming intrahepatic cholangiocarcinoma. Liver International 2022; 42(4) doi: 10.1111/liv.15196
|
| 202 |
|
| 203 |
Zetao Yu, Qingqiang Ni, Hongtao Jia, Hengjun Gao, Faji Yang, Huaqiang Zhu, Fangfeng Liu, Jianlu Wang, Xu Zhou, Hong Chang, Jun Lu. Prognostic analysis of radical resection for iCCAphl and iCCApps: A retrospective cohort study. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.992606
|
| 204 |
Kai-pu Jin, Rou-fan Sheng, Chun Yang, Meng-su Zeng. Combined arterial and delayed enhancement patterns of MRI assist in prognostic prediction for intrahepatic mass-forming cholangiocarcinoma (IMCC). Abdominal Radiology 2022; 47(2) doi: 10.1007/s00261-021-03292-5
|
| 205 |
Gábor Lendvai, Tímea Szekerczés, Ildikó Illyés, Milán Csengeri, Krisztina Schlachter, Erzsébet Szabó, Gábor Lotz, András Kiss, Katalin Borka, Zsuzsa Schaff, Vladimir Trajkovic. Autophagy activity in cholangiocarcinoma is associated with anatomical localization of the tumor. PLOS ONE 2021; 16(6) doi: 10.1371/journal.pone.0253065
|
| 206 |
洪珏 朱. Current Status of Clinical Diagnosis and Therapy for Intraductal Papillary Neoplasm of the Bile Duct. Advances in Clinical Medicine 2025; 15(03) doi: 10.12677/acm.2025.153699
|
| 207 |
XIONGFEI CHEN, MINGZHU SUN, YAZHUO HU, HONGHONG ZHANG, ZHANBO WANG, NINGXIN ZHOU, XINYUN YAN. FXYD6 is a new biomarker of cholangiocarcinoma. Oncology Letters 2014; 7(2) doi: 10.3892/ol.2013.1727
|
| 208 |
Namsrai Baterdene, Shin Hwang, Jong-Wook Lee, Min-Jae Jung, Heeji Shin, Hye Kyoung Seo, Myeong-Hwan Kim, Sung-Koo Lee. Surgical treatment of mucin-producing cholangiocarcinoma arising from intraductal papillary neoplasm of the intrahepatic bile duct: a report of 2 cases. Korean Journal of Hepato-Biliary-Pancreatic Surgery 2016; 20(3) doi: 10.14701/kjhbps.2016.20.3.137
|
| 209 |
JENNIFER ZHANG, MICHAEL N. MAVROS, TIMOTHY M. PAWLIK. Clinical Interventional Oncology. 2014; doi: 10.1016/B978-1-4557-1221-2.00019-2
|
| 210 |
Santiago Sucre, Andrea Bullock, Mary Linton Peters. Efficacy of dual checkpoint inhibitors in a patient with a mixed hepatocellular cholangiocarcinoma. BMJ Case Reports 2024; 17(5) doi: 10.1136/bcr-2023-255003
|
| 211 |
Mirella Pastore, Giulia Lori, Alessandra Gentilini, Maria Letizia Taddei, Giovanni Di Maira, Claudia Campani, Stefania Recalcati, Pietro Invernizzi, Fabio Marra, Chiara Raggi. Multifaceted Aspects of Metabolic Plasticity in Human Cholangiocarcinoma: An Overview of Current Perspectives. Cells 2020; 9(3) doi: 10.3390/cells9030596
|
| 212 |
Sravanthi Mantripragada, Ashish Chawla. Cholangiocarcinoma: Part 1, Pathological and Morphological Subtypes, Spectrum of Imaging Appearances, Prognostic Factors and Staging. Current Problems in Diagnostic Radiology 2022; 51(3) doi: 10.1067/j.cpradiol.2021.03.008
|
| 213 |
Napat Armartmuntree, Mariko Murata, Anchalee Techasen, Puangrat Yongvanit, Watcharin Loilome, Nisana Namwat, Chawalit Pairojkul, Chadamas Sakonsinsiri, Somchai Pinlaor, Raynoo Thanan. Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis. Redox Biology 2018; 14 doi: 10.1016/j.redox.2017.11.011
|
| 214 |
Tianzuo Zhan, Johannes Betge, Nadine Schulte, Lena Dreikhausen, Michael Hirth, Moying Li, Philip Weidner, Antonia Leipertz, Andreas Teufel, Matthias P. Ebert. Digestive cancers: mechanisms, therapeutics and management. Signal Transduction and Targeted Therapy 2025; 10(1) doi: 10.1038/s41392-024-02097-4
|
| 215 |
|
| 216 |
Gerly E. Guzmán-Calderon, Carlos Huaraca, Brandon Bravo, Joseph Arzapalo. Common bile duct polyp: an infrequent cause of jaundice and biliary obstruction. Endoscopy 2024; 56(S 01) doi: 10.1055/a-2271-5732
|
| 217 |
Xiao-fang Zhang, Min Dong, Yu-hang Pan, Jian-ning Chen, Xiang-qi Huang, Yi Jin, Chun-kui Shao. Expression pattern of cancer-associated fibroblast and its clinical relevance in intrahepatic cholangiocarcinoma. Human Pathology 2017; 65 doi: 10.1016/j.humpath.2017.04.014
|
| 218 |
Supinda Koonmee, Prakasit Sa-ngiamwibool, Chaiwat Aphivatanasiri, Waritta Kunprom, Piyapharom Intarawichian, Walailak Bamrungkit, Sakkarn Sangkhamanon, Malinee Thanee. Liver Fluke, Opisthorchis viverrini Related Cholangiocarcinoma. Recent Results in Cancer Research 2023; 219 doi: 10.1007/978-3-031-35166-2_5
|
| 219 |
Andrea Siobhan Kierans, Guilherme M. Cunha, Michael J. King, Robert M. Marks, Frank H. Miller, Jeong Min Lee, Aliya Qayyum. Standardized reporting of intrahepatic cholangiocarcinoma. Abdominal Radiology 2024; 50(4) doi: 10.1007/s00261-024-04582-4
|
| 220 |
Tsutomu Takenami, Shimpei Maeda, Hideaki Karasawa, Takashi Suzuki, Toru Furukawa, Takanori Morikawa, Tatsuyuki Takadate, Hiroki Hayashi, Kei Nakagawa, Fuyuhiko Motoi, Takeshi Naitoh, Michiaki Unno. Novel biomarkers distinguishing pancreatic head Cancer from distal cholangiocarcinoma based on proteomic analysis. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5548-x
|
| 221 |
Steffen Zender, Irina Nickeleit, Torsten Wuestefeld, Inga Sörensen, Daniel Dauch, Przemyslaw Bozko, Mona El-Khatib, Robert Geffers, Hueseyin Bektas, Michael P. Manns, Achim Gossler, Ludwig Wilkens, Ruben Plentz, Lars Zender, Nisar P. Malek. A Critical Role for Notch Signaling in the Formation of Cholangiocellular Carcinomas. Cancer Cell 2013; 23(6) doi: 10.1016/j.ccr.2013.04.019
|
| 222 |
Yueh-Chun Lee, Huey-En Tzeng, Hui-Hsuan Lin, Kuei-Yang Hsiao. Circular RNA in liquid biopsy as biomarkers toward precision medicine. Molecular Therapy - Nucleic Acids 2023; 31 doi: 10.1016/j.omtn.2023.02.023
|
| 223 |
Yongjun Liu, Matthew M. Yeh. Bile duct dysplasia and associated invasive carcinoma: clinicopathological features, diagnosis, and practical challenges. Human Pathology 2023; 132 doi: 10.1016/j.humpath.2022.06.012
|
| 224 |
Ashini Shah, Brinda S. Chandibhamar, Amisha Gami, Priti Trivedi. Case report of intrahepatic cholangiocarcinoma showing thyroid like follicular pattern: a rare morphological variant. European Journal of Medical Case Reports 2020; 4(9) doi: 10.24911/ejmcr/173-1554056047
|
| 225 |
Jae Hoon Lim, Kee-Taek Jang, Jung Hoon Kim. Neoplasms of the Biliary Tract. 2021; doi: 10.1007/978-981-15-6659-2_1
|
| 226 |
Yurie Soejima, Miho Takeuchi, Takumi Akashi, Motoji Sawabe, Toshio Fukusato. β4 and β6 Integrin Expression Is Associated with the Subclassification and Clinicopathological Features of Intrahepatic Cholangiocarcinoma. International Journal of Molecular Sciences 2018; 19(4) doi: 10.3390/ijms19041004
|
| 227 |
Xuefeng Li, Yukinori Koyama, Kojiro Taura, Takahiro Nishio, Tomoaki Yoh, Hiroto Nishino, Yusuke Uemoto, Yusuke Kimura, Daichi Nakamura, Nguyen Hai Nam, Motohiko Sato, Satoru Seo, Keiko Iwaisako, Etsuro Hatano. High expression of autotaxin is associated with poor recurrence‐free survival in cholangiocarcinoma. Hepatology Research 2024; 54(9) doi: 10.1111/hepr.14031
|
| 228 |
Calvin T. Sung, Anup Shetty, Christine O. Menias, Roozbeh Houshyar, Shreya Chatterjee, Thomas K. Lee, Paul Tung, Mohammed Helmy, Chandana Lall. Collision and composite tumors; radiologic and pathologic correlation. Abdominal Radiology 2017; 42(12) doi: 10.1007/s00261-017-1200-x
|
| 229 |
Hu Liu, Tian Lan, Yun-shi Cai, Ying-hao lyu, Jiang Zhu, Si-nan Xie, Feng-juan Hu, Chang Liu, Hong Wu. Predicting prognosis in intrahepatic cholangiocarcinoma by the histopathological features. Asian Journal of Surgery 2024; 47(6) doi: 10.1016/j.asjsur.2024.03.085
|
| 230 |
Carlie S. Sigel, Esther Drill, Yi Zhou, Olca Basturk, Gokce Askan, Linda M. Pak, Efsevia Vakiani, Tao Wang, Thomas Boerner, Richard K.G. Do, Amber L. Simpson, William Jarnagin, David S. Klimstra. Intrahepatic Cholangiocarcinomas Have Histologically and Immunophenotypically Distinct Small and Large Duct Patterns. American Journal of Surgical Pathology 2018; 42(10) doi: 10.1097/PAS.0000000000001118
|
| 231 |
Gianluca Carnevale, Guido Carpino, Vincenzo Cardinale, Alessandra Pisciotta, Massimo Riccio, Laura Bertoni, Lara Gibellini, Sara De Biasi, Lorenzo Nevi, Daniele Costantini, Diletta Overi, Andrea Cossarizza, Anto de Pol, Eugenio Gaudio, Domenico Alvaro. Activation of Fas/FasL pathway and the role of c-FLIP in primary culture of human cholangiocarcinoma cells. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-14838-3
|
| 232 |
Xichun Sun. Well-Differentiated Malignancies. Current Clinical Pathology 2015; doi: 10.1007/978-1-4939-1692-4_7
|
| 233 |
Yuanfu Qiu, Jian He, Xinliang Chen, Pinbo Huang, Kaishun Hu, Haiyan Yan. The diagnostic value of five serum tumor markers for patients with cholangiocarcinoma. Clinica Chimica Acta 2018; 480 doi: 10.1016/j.cca.2018.02.008
|
| 234 |
Gi-Woong Jang, Shin Hwang, Yong-Joo Lee, Ki-Hun Kim, Kwang-Min Park, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Gil-Chun Park, Sung-Gyu Lee. Clinicopathological features of the intraductal papillary neoplasms of the intrahepatic bile duct. Korean Journal of Hepato-Biliary-Pancreatic Surgery 2012; 16(4) doi: 10.14701/kjhbps.2012.16.4.138
|
| 235 |
L. Zender, N. P. Malek. Diagnostik und Therapie des cholangiozellulären Karzinoms. Der Internist 2016; 57(12) doi: 10.1007/s00108-016-0128-5
|
| 236 |
Shinichi Aishima. Diversity of tumor vessels in intrahepatic cholangiocarcinoma. Kanzo 2015; 56(8) doi: 10.2957/kanzo.56.406
|
| 237 |
Xizi Shen, Xingping Shen. A potential role for aspirin in the prevention and treatment of cholangiocarcinoma. International Journal of Cancer 2021; 148(6) doi: 10.1002/ijc.33323
|
| 238 |
Jesus M. Banales, Vincenzo Cardinale, Guido Carpino, Marco Marzioni, Jesper B. Andersen, Pietro Invernizzi, Guro E. Lind, Trine Folseraas, Stuart J. Forbes, Laura Fouassier, Andreas Geier, Diego F. Calvisi, Joachim C. Mertens, Michael Trauner, Antonio Benedetti, Luca Maroni, Javier Vaquero, Rocio I. R. Macias, Chiara Raggi, Maria J. Perugorria, Eugenio Gaudio, Kirsten M. Boberg, Jose J. G. Marin, Domenico Alvaro. Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nature Reviews Gastroenterology & Hepatology 2016; 13(5) doi: 10.1038/nrgastro.2016.51
|
| 239 |
Liang Qiao, Yu-Gang Luo, Qing-Ying Wang, Tian Yuan, Meng Xu, Guang-Bing Xiong, Feng Zhu. Artificial intelligence in the diagnosis and prognosis of intrahepatic cholangiocarcinoma: Applications and challenges. World Journal of Gastrointestinal Oncology 2025; 17(10): 111367 doi: 10.4251/wjgo.v17.i10.111367
|
| 240 |
John Bridgewater, Peter R. Galle, Shahid A. Khan, Josep M. Llovet, Joong-Won Park, Tushar Patel, Timothy M. Pawlik, Gregory J. Gores. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. Journal of Hepatology 2014; 60(6) doi: 10.1016/j.jhep.2014.01.021
|
| 241 |
Pirawan Poosekeaw, Chawalit Pairojkul, Banchob Sripa, Prakasit Sa Ngiamwibool, Sitthichai Iamsaard, Chadamas Sakonsinsiri, Raynoo Thanan, Piti Ungarreevittaya, Konradin Metze. Adaptor protein XB130 regulates the aggressiveness of cholangiocarcinoma. PLOS ONE 2021; 16(11) doi: 10.1371/journal.pone.0259075
|
| 242 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; doi: 10.1007/978-3-319-26587-2_35-1
|
| 243 |
Iris E.M. de Jong, Otto B. van Leeuwen, Ton Lisman, Annette S.H. Gouw, Robert J. Porte. Repopulating the biliary tree from the peribiliary glands. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(4) doi: 10.1016/j.bbadis.2017.07.037
|
| 244 |
Aiping Tian, Ke Pu, Boxuan Li, Min Li, Xiaoguang Liu, Liping Gao, Xiaorong Mao. Weighted gene coexpression network analysis reveals hub genes involved in cholangiocarcinoma progression and prognosis. Hepatology Research 2019; 49(10) doi: 10.1111/hepr.13386
|
| 245 |
Rodrigo Mansilla-Vivar, Camila Bahamonde-Ovando, Renato Carrasco-Farias. Diagnosis and Management of Cholangiocarcinoma. 2021; doi: 10.1007/978-3-030-70936-5_12
|
| 246 |
Md. Hafiz Uddin, Min-Ho Choi, Woo Ho Kim, Ja-June Jang, Sung-Tae Hong, Xiao-Nong Zhou. Involvement of PSMD10, CDK4, and Tumor Suppressors in Development of Intrahepatic Cholangiocarcinoma of Syrian Golden Hamsters Induced by Clonorchis sinensis and N-Nitrosodimethylamine. PLOS Neglected Tropical Diseases 2015; 9(8) doi: 10.1371/journal.pntd.0004008
|
| 247 |
Agrin Moeini, Philipp K. Haber, Daniela Sia. Cell of origin in biliary tract cancers and clinical implications. JHEP Reports 2021; 3(2) doi: 10.1016/j.jhepr.2021.100226
|
| 248 |
Sophie Pirenne, Frédéric P. Lemaigre. Genetically engineered animal models of biliary tract cancers. Current Opinion in Gastroenterology 2020; 36(2) doi: 10.1097/MOG.0000000000000610
|
| 249 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; doi: 10.1007/978-3-319-26956-6_29
|
| 250 |
Hyungjin Rhee, Jung Eun Ko, Taek Chung, Byul A Jee, So Mee Kwon, Ji Hae Nahm, Jae Yeon Seok, Jeong Eun Yoo, Jin‐Sub Choi, Snorri S. Thorgeirsson, Jesper B. Andersen, Hye Sun Lee, Hyun Goo Woo, Young Nyun Park. Transcriptomic and histopathological analysis of cholangiolocellular differentiation trait in intrahepatic cholangiocarcinoma. Liver International 2018; 38(1) doi: 10.1111/liv.13492
|
| 251 |
Lorenzo Nevi, Sabina Di Matteo, Guido Carpino, Ilaria Grazia Zizzari, Samira Safarikia, Valeria Ambrosino, Daniele Costantini, Diletta Overi, Antonella Giancotti, Marco Monti, Daniela Bosco, Valerio De Peppo, Andrea Oddi, Agostino Maria De Rose, Fabio Melandro, Maria Consiglia Bragazzi, Jessica Faccioli, Sara Massironi, Gian Luca Grazi, Pierluigi Benedetti Panici, Paquale Bartomeo Berloco, Felice Giuliante, Vincenzo Cardinale, Pietro Invernizzi, Giuseppina Caretti, Eugenio Gaudio, Domenico Alvaro. DCLK1, a Putative Stem Cell Marker in Human Cholangiocarcinoma. Hepatology 2021; 73(1) doi: 10.1002/hep.31571
|
| 252 |
Michelle L. DeOliveira. Liver transplantation for cholangiocarcinoma. Current Opinion in Organ Transplantation 2014; 19(3) doi: 10.1097/MOT.0000000000000087
|
| 253 |
Yasuni Nakanuma, Takashi Miyata, Tsuneyuki Uchida. Latest advances in the pathological understanding of cholangiocarcinomas. Expert Review of Gastroenterology & Hepatology 2016; 10(1) doi: 10.1586/17474124.2016.1104246
|
| 254 |
Motoko Sasaki, Yasuni Nakanuma. New concept: cellular senescence in pathophysiology of cholangiocarcinoma. Expert Review of Gastroenterology & Hepatology 2016; 10(5) doi: 10.1586/17474124.2016.1133291
|
| 255 |
Vladimir Pecenka, Petr Pajer, Vít Karafiat, Petra Kasparova, Jana Dudlova, Michal Dvorak, Karen L. Beemon.
HRAS
,
EGFR
,
MET
, and
RON
Genes Are Recurrently Activated by Provirus Insertion in Liver Tumors Induced by the Retrovirus Myeloblastosis-Associated Virus 2
. Journal of Virology 2017; 91(20) doi: 10.1128/JVI.00467-17
|
| 256 |
Sukanya Roy, Shannon Glaser, Sanjukta Chakraborty. Inflammation and Progression of Cholangiocarcinoma: Role of Angiogenic and Lymphangiogenic Mechanisms. Frontiers in Medicine 2019; 6 doi: 10.3389/fmed.2019.00293
|
| 257 |
Tetsuo Tsukahara, Yoshie Shimoyama, Tomoki Ebata, Yukihiro Yokoyama, Tsuyoshi Igami, Gen Sugawara, Takashi Mizuno, Junpei Yamaguchi, Shigeo Nakamura, Masato Nagino. Cholangiocarcinoma with intraductal tubular growth pattern versus intraductal papillary growth pattern. Modern Pathology 2016; 29(3) doi: 10.1038/modpathol.2015.152
|
| 258 |
Jesus M. Banales, Jose J. G. Marin, Angela Lamarca, Pedro M. Rodrigues, Shahid A. Khan, Lewis R. Roberts, Vincenzo Cardinale, Guido Carpino, Jesper B. Andersen, Chiara Braconi, Diego F. Calvisi, Maria J. Perugorria, Luca Fabris, Luke Boulter, Rocio I. R. Macias, Eugenio Gaudio, Domenico Alvaro, Sergio A. Gradilone, Mario Strazzabosco, Marco Marzioni, Cédric Coulouarn, Laura Fouassier, Chiara Raggi, Pietro Invernizzi, Joachim C. Mertens, Anja Moncsek, Sumera I. Ilyas, Julie Heimbach, Bas Groot Koerkamp, Jordi Bruix, Alejandro Forner, John Bridgewater, Juan W. Valle, Gregory J. Gores. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nature Reviews Gastroenterology & Hepatology 2020; 17(9) doi: 10.1038/s41575-020-0310-z
|
| 259 |
Vincenza Granata, Roberta Grassi, Roberta Fusco, Sergio Venanzio Setola, Andrea Belli, Alessandro Ottaiano, Guglielmo Nasti, Michelearcangelo La Porta, Ginevra Danti, Salvatore Cappabianca, Carmen Cutolo, Antonella Petrillo, Francesco Izzo. Intrahepatic cholangiocarcinoma and its differential diagnosis at MRI: how radiologist should assess MR features. La radiologia medica 2021; 126(12) doi: 10.1007/s11547-021-01428-7
|
| 260 |
Monika Vyas, Vikram Deshpande. How do I distinguish cholangiocarcinoma from metastatic carcinoma and why does it matter?. Diagnostic Histopathology 2022; 28(2) doi: 10.1016/j.mpdhp.2021.11.002
|
| 261 |
|
| 262 |
Rebecca M. Dodson, Matthew J. Weiss, David Cosgrove, Joseph M. Herman, Ihab Kamel, Robert Anders, Jean-Francois H. Geschwind, Timothy M. Pawlik. Intrahepatic Cholangiocarcinoma: Management Options and Emerging Therapies. Journal of the American College of Surgeons 2013; 217(4) doi: 10.1016/j.jamcollsurg.2013.05.021
|
| 263 |
Timothy Kendall, Joanne Verheij, Eugenio Gaudio, Matthias Evert, Maria Guido, Benjamin Goeppert, Guido Carpino. Anatomical, histomorphological and molecular classification of cholangiocarcinoma. Liver International 2019; 39(S1) doi: 10.1111/liv.14093
|
| 264 |
Diyu Chen, Hao Wu, Xiaode Feng, Yunhao Chen, Zhen Lv, Vishnu Goutham Kota, Junru Chen, Wenxuan Wu, Yuejie Lu, Hua Liu, Yanpeng Zhang, Shusen Zheng, Jian Wu. DNA Methylation of Cannabinoid Receptor Interacting Protein 1 Promotes Pathogenesis of Intrahepatic Cholangiocarcinoma Through Suppressing Parkin‐Dependent Pyruvate Kinase M2 Ubiquitination. Hepatology 2021; 73(5) doi: 10.1002/hep.31561
|
| 265 |
Hyung Sun Kim, Mee Joo Kang, Jingu Kang, Kyubo Kim, Bohyun Kim, Seong-Hun Kim, Soo Jin Kim, Yong-Il Kim, Joo Young Kim, Jin Sil Kim, Haeryoung Kim, Hyo Jung Kim, Ji Hae Nahm, Won Suk Park, Eunkyu Park, Joo Kyung Park, Jin Myung Park, Byeong Jun Song, Yong Chan Shin, Keun Soo Ahn, Sang Myung Woo, Jeong Il Yu, Changhoon Yoo, Kyoungbun Lee, Dong Ho Lee, Myung Ah Lee, Seung Eun Lee, Ik Jae Lee, Huisong Lee, Jung Ho Im, Kee-Taek Jang, Hye Young Jang, Sun-Young Jun, Hong Jae Chon, Min Kyu Jung, Yong Eun Chung, Jae Uk Chong, Eunae Cho, Eui Kyu Chie, Sae Byeol Choi, Seo-Yeon Choi, Seong Ji Choi, Joon Young Choi, Hye-Jeong Choi, Seung-Mo Hong, Ji Hyung Hong, Tae Ho Hong, Shin Hye Hwang, In Gyu Hwang, Joon Seong Park. Practice guidelines for managing extrahepatic biliary tract cancers. Annals of Hepato-Biliary-Pancreatic Surgery 2024; 28(2) doi: 10.14701/ahbps.23-170
|
| 266 |
Tommaso Stecca, Bruno Pauletti, Luca Bonariol, Ezio Caratozzolo, Marco Massani. Bile Duct Cancer. 2019; doi: 10.5772/intechopen.85840
|
| 267 |
Tiffany Priyanthi Hennedige, Wee Thong Neo, Sudhakar Kundapur Venkatesh. Imaging of malignancies of the biliary tract- an update. Cancer Imaging 2014; 14(1) doi: 10.1186/1470-7330-14-14
|
| 268 |
Douglas C. Vander Kooi, Bobby T. Kalb, Diego R. Martin. Zakim and Boyer's Hepatology. 2018; doi: 10.1016/B978-0-323-37591-7.00010-0
|
| 269 |
Kengo Yoshimitsu. Differentiation of two subtypes of intrahepatic cholangiocarcinoma: imaging approach. European Radiology 2019; 29(6) doi: 10.1007/s00330-019-06135-6
|